**Telemedicine Programs in Respiratory Diseases**

Gonzalo Segrelles-Calvo and Daniel López-Padilla

Additional information is available at the end of the chapter

http://dx.doi.org/10.5772/64705

#### **Abstract**

[118] Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. *Diabetes Care*. 2010;33(8):

[119] Javitt JC, Reese CS, Derrick MK. Deployment of an mHealth patient monitoring solution for diabetes-improved glucose monitoring leads to reduction in medical

[120] Levin K, Madsen JR, Petersen I, Wanscher CE, Hangaard J. Telemedicine diabetes consultations are cost-effective, and effects on essential diabetes treatment parameters are similar to conventional treatment: 7-year results from the Svendborg Telemedicine

[121] Gordon LG, Bird D, Oldenburg B, Friedman RH, Russell AW, Scuffham PA. A costeffectiveness analysis of a telephone-linked care intervention for individuals with type 2 diabetes. *Diabetes Res Clin Pr*. 2014;104(1):103–111. DOI: 10.1016/j.diabres.2013.12.032.

[122] Henderson C, Knapp M, Fernández JL, et al. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.

[123] Zhai YK, Zhu WJ, Cai YL, Sun DX, Zhao J. Clinical- and cost-effectiveness of teleme‐ dicine in type 2 diabetes mellitus: a systematic review and meta-analysis. *Med*.

[124] Graschew G, Rakowsky S. Telemedicine Techniques and Applications. Intech. [Inter‐ net]. 2011. Available from: http://www.intechopen.com/books/telemedicine-techni‐

[125] Keith-Hynes P, Guerlain S, Mize B, et al. DiAs user interface: a patient-centric interface for mobile artificial pancreas systems. *J Diabetes Sci Technol*. 2013;7(6):1416–1426. DOI:

1872–1894. DOI: 10.2337/dc10-0843.

56 Mobile Health Technologies - Theories and Applications

expenditure. *US Endocrinol*. 2013;9(2):119–123.

*BMJ*. 2013;346:f1035. DOI: 10.1136/bmj.f1035.

10.1177/193229681300700602.

2014;93(28):e312. DOI: 10.1097/MD.0000000000000312.

ques-and-applications [Accessed: 2016-02-15]. DOI: 10.5772/724

Diabetes Project. *J Diabetes Sci Technol*. 2013;7(3):587–595.

Telemedicine programs are widely used in respiratory diseases, more often in patients with chronic obstructive pulmonary diseases (COPD). Telemedicine platforms use several devices to measure vital signs such as heart rate, respiratory rate, pulsioxime‐ try or blood pressure between others. It is not unusual that patients could do question‐ naires about clinical situation or communicate with their nurses via telephone, videocalling and/or Skype. The majority of results has been positive, with reduction in the number of emergency visits, hospitalizations and noninvasive ventilations. Despite their promising results, telemedicine programs/platforms are slow to implement. In this chapter, we reviewed some of the factors related to telemedicine implementation such as patients' adherence, impact of telemedicine design and professionals' resistance to change between others.

**Keywords:** COPD, eHealth, home telemonitoring, telemedicine, telemedicine plat‐ forms
